However, in order to prevent delays or interrupt a course of treatment or other situations in which refusal of a shipment at the border could create a health risk, inspectors may allow entry of an initial 3-month supply of a drug, if the drug is packaged in hospital or pharmacy dispensed packaging. At this time, the recipient will be informed that all future shipments will be detained and that either a Canadian source should be used or that their doctor should obtain a foreign supply through the Special Access Programme for drugs not available in Canada.
For further
information Write:

Therapeutic Products Programme
Health Canada
Holland Cross, Tower B
1600 Scott Street, 2nd Floor
Address Locator 3102D1
Ottawa, Ontario K1A 1B6

or visit our website:

www.hc-sc.gc.ca/hpb-dgps/therapeut